<p>Donna H. Ryan, MD, Professor Emerita at Pennington Biomedical Research Center, joins the podcast to discuss obesity therapies and the results of the SELECT trial.</p>
<h4><span style="text-decoration: underline;">Highlights</span></h4>
<p>TIMI turning 40 | Exciting Storylines in 2024 | A Graveyard of Weight Loss Drugs | Breakthrough of Semaglutide (Ozempic/Weygovy/Rybelsus) | SELECT Trial | Obesity as a Disease | Nick and David’s Podcast Resolutions</p>

<audio class="wp-audio-shortcode" id="audio-8003-1" preload="none" style="width: 100%;" controls="controls"><source type="audio/mpeg" src="https://timi.org/wp-content/uploads/2024/01/S2E4-Donna-Ryan.mp3?_=1" /><a href="https://timi.org/wp-content/uploads/2024/01/S2E4-Donna-Ryan.mp3">https://timi.org/wp-content/uploads/2024/01/S2E4-Donna-Ryan.mp3</a></audio>

S2E5 – Angina management and the ORBITA-2 trial with Dr. Rasha Al-Lamee

The TIMI Talks podcast provides a unique and trusted forum for engaging the cardiology community in the design, execution, and interpretation of randomized clinical trials.  TIMI Talks will bring you expert roundtable discussions on the latest clinical trials, cardiology meeting recaps, as well as feature discussions on statistical considerations, new TIMI publications, and academic career development.